CBL vs IPD

ASX Healthcare sector comparison — updated 23 Jul 2026 — Healthcare sector

CBL

CTRLBIONIC FPO [CBL]

51MEDIUM

IPD

IMPEDIMED FPO [IPD]

51MEDIUM

Score Breakdown

CBL IPD
Technical
63
51
Catalyst
61
53
Sentiment
50
50
Fundamental
46
85
Momentum
75
30
Risk Gate
50
27

Key Metrics

CBL Metric IPD
$31.2MMarket Cap$18.3M
571KAvg Volume (20d)6.1M
N/AShort InterestN/A
$0.09552-Week High$0.059
$0.03252-Week Low$0.005
+6.1%Daily Change+0.0%
$0.070Reference Price$0.005
-91.6%ROE-117.9%
-107.0%Profit Margin-171.3%

Active Signals

CBL Signals

RSI drifting toward oversold territory — worth watching
Stochastic just turned bullish from a low level — early reversal sign
Trading below both moving averages — the trend is working against this one
Above-average volume (1.8x) on a green day — buyers stepping up
Lagging the Small Ords index — relative strength of 0.86, underperforming its peers
Volatility is contracting — like a spring being compressed, breakouts often follow
Trading above the 200-day average — the long-term trend is on your side
Low cash runway (3 quarters) - dilution risk

IPD Signals

RSI drifting toward oversold territory — worth watching
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Volume surging at 4.1x normal while price falls — heavy selling pressure
Sitting near support — this level has held before and could attract buyers again
Took a hit — down 16.7% over the last 5 days
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Volatility is contracting — like a spring being compressed, breakouts often follow

Ask Scout AI to compare CBL and IPD in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

ACL vs IPD →IDX vs IPD →ACL vs CBL →CBL vs IDX →ACL vs IDX →
CBL Full Analysis → IPD Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).